Genoway SA
PAR:ALGEN

Watchlist Manager
Genoway SA Logo
Genoway SA
PAR:ALGEN
Watchlist
Price: 3.8 EUR -0.78% Market Closed
Market Cap: 35.2m EUR
Have any thoughts about
Genoway SA?
Write Note

Genoway SA
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genoway SA
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Genoway SA
PAR:ALGEN
Common Shares Outstanding
€8.7m
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
4%
Valneva SE
PAR:VLA
Common Shares Outstanding
€139.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innate Pharma SA
PAR:IPH
Common Shares Outstanding
€80.9m
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
4%
G
Genfit SA
PAR:GNFT
Common Shares Outstanding
€49.8m
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
8%
Inventiva SA
PAR:IVA
Common Shares Outstanding
€52.5m
CAGR 3-Years
11%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Common Shares Outstanding
€10.9m
CAGR 3-Years
-1%
CAGR 5-Years
0%
CAGR 10-Years
14%
No Stocks Found

Genoway SA
Glance View

Market Cap
33.1m EUR
Industry
Biotechnology

genOway SA engages in the development of genetically-modified mouse, rat, and cellular models for biopharmaceutical and research companies. The company is headquartered in Lyon, Auvergne-Rhone-Alpes. The company went IPO on 2007-05-04. The firm offers an array of services which include site specific transgenesis, random insertion based transgenic models, gene overexpression, humanization, gene deletion and gene knock-down (RNA interference). The Company’s clients include multinational biopharmaceutical companies, such as Roche, Novartis and Servier, as well as universities and research institutes, notably Boston University, University of Tokyo, Johann Wolfgang Goethe University Hospital Frankfurt and Centre National de Genotypage.

ALGEN Intrinsic Value
4.89 EUR
Undervaluation 22%
Intrinsic Value
Price

See Also

What is Genoway SA's Common Shares Outstanding?
Common Shares Outstanding
8.7m EUR

Based on the financial report for Jun 30, 2024, Genoway SA's Common Shares Outstanding amounts to 8.7m EUR.

What is Genoway SA's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
4%

Over the last year, the Common Shares Outstanding growth was -1%. The average annual Common Shares Outstanding growth rates for Genoway SA have been 2% over the past three years , 8% over the past five years , and 4% over the past ten years .

Back to Top